VONENTIAL Trademark

Trademark Overview


On Friday, April 8, 2022, a trademark application was filed for VONENTIAL with the United States Patent and Trademark Office. The USPTO has given the VONENTIAL trademark a serial number of 97353394. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 10, 2024. This trademark is owned by Agouron Pharmaceuticals, LLC. The VONENTIAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
vonential

General Information


Serial Number97353394
Word MarkVONENTIAL
Filing DateFriday, April 8, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgouron Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Party NameAgouron Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, April 12, 2022NEW APPLICATION ENTERED
Tuesday, April 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Thursday, January 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 6, 2023SOU EXTENSION 1 GRANTED
Friday, October 6, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 6, 2023SOU EXTENSION 1 FILED
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2024SOU EXTENSION 2 FILED
Tuesday, April 9, 2024SOU EXTENSION 2 GRANTED
Thursday, October 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU EXTENSION 3 GRANTED
Thursday, October 10, 2024SOU EXTENSION 3 FILED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED